Progyny, Inc.PGNY

$26.08-0.23 (-0.87%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$2B
Mid-cap
+70%
2019 — today
10-Year Price
+64%
2019 — today
52-Week Range
$16.30$28.42
Current $26.08· 81%

Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.

Valuation in context

P/E ratio
33.9
Below average
Below the 10-year average
P/B ratio
5.0
Below average
Below the 10-year average
EV / EBITDA
18.9
Near historic low
Near historic low — last 10 years
PEG ratio
5.4
Near historic high
Near historic highs — last 10 years
FCF Yield
8.3%
Historically high
Historically high relative to the last 10 years
Free · No credit card needed

Get alerted when PGNY is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.